Cannabis effects on opioid use in withdrawal
Treatments studied
Part of Mental health clinical trials.
This study tests whether cannabis can help people with opioid withdrawal and reduce opioid use. You will stay in a research center and receive cannabis in a controlled setting while researchers monitor your symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate or severe opioid use disorder and experience withdrawal symptoms when you stop using opioids.
- You are not allergic or have had bad reactions to cannabis or opioids.
- You are willing to stay in the hospital research center for about 6 weeks.
- You are not currently seeking treatment to stop using opioids.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether cannabis can help people with moderate to severe opioid use disorder manage withdrawal symptoms.
This Phase 1 trial studies cannabis in people with opioid use disorder. The goal is to better understand how it may affect opioid use disorder, while monitoring safety.
This trial tests if adding a specific cannabis product to standard methadone treatment helps people with opioid use disorder. It's for adults over 25 who recently started methadone and have used cannabis before.
This trial tests whether two cannabis-based medicines, dronabinol and Epidiolex, can help ease withdrawal symptoms or cravings in people who have just started buprenorphine for opioid use disorder. It may be a good fit if you are early in treatment and still have symptoms or slip-ups.
This study tests whether a combination of THC and CBD can help people who have both opioid use disorder and chronic low back pain. You would need to be on a stable dose of methadone and have used cannabis at least once in your life.
This study aims to better understand how people experience opioid withdrawal. You will be asked to describe your symptoms, which may help develop a new tool to measure withdrawal more accurately.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.